Alzamend Neuro will present at the Sequire Biotechnology conferenceBy Publishing TeamJanuary 26, 2023 Presenting Thursday, February 2, 2023 at 10:30 a.m. ET Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend), a clinical-stage biopharmaceutical company focused…
Invitation to Surgical Science Financial Markets Day 2023By Publishing TeamJanuary 19, 2023 LOCATIONRoyal Park, Stockholm, SwedenFrösundaviks gone 15, 169 03 SolnaAGENDA▪ 2 p.m.: Gisli Hennermark CEO, welcome▪ 2:20 p.m.: Anna Ahlberg CFO…
